Quality of life (QOL) among patients (pts) with HER2+ breast cancer (bc) treated with adjuvant lapatinib and/or trastuzumab in the ALTTO study (BIG 2-06, Alliance N063D).
- Citation:
- J Clin Oncol vol 32 (5s) (suppl; abstr 647)
- Meeting Instance:
- ASCO 2014
- Year:
- 2014
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Amylou C. Dueck
- Authors:
- Amylou C. Dueck David W. Hillman Lisa A. Kottschade Michele Y. Halyard Jeff A. Sloan Lynn M. Flickinger Antonio C. Wolff Lyndsay Harris Julie Gralow Kathleen I. Pritchard Susan Ellard Nguyet Le-Lindqwister Frances M. Boyle Evandro de Azambuja Worta J. McCaskill-Stevens Jo Anne Zujewski Martine J. Piccart-Gebhart Edith A. Perez
- Networks:
- Study
- NCCTG-N063D
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: